[1] DIEHL AM, DAY C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med, 2017, 377 (21) :2063-2072.
|
[2] LONARDO A, BYRNE CD, CALDWELL SH, et al. Global epidemiology of nonalcoholic fatty liver disease:Meta-analytic assessment of prevalence, incidence, and outcomes[J].Hepatology, 2016, 64 (4) :1388-1389.
|
[3] MANN JP, TANG GY, NOBILI V, et al. Evaluations of lifestyle, dietary, and pharmacologic treatments for pediatric nonalcoholic fatty liver disease:A systematic review[J]. Clin Gastroenterol Hepatol, 2018.[Epub ahead of print]
|
[4] MYERS DM, DEWALL CN. Social Psychology[M]. 11th ed.Worth Publishers, 2015.
|
[5] LIAO Q, ZHENG Y, LIU XF, et al. Correlation of non-alcoholic fatty liver disease and depression in an elderly Chinese population[J]. J Third Milit Med Univ, 2017, 39 (19) :1954-1959. (in Chinese) 廖倩, 郑怡, 刘羞菲, 等.中老年人群非酒精性脂肪肝与抑郁症的相关性研究[J].第三军医大学学报, 2017, 39 (19) :1954-1959.
|
[6] ELWING JE, LUSTMAN PJ, WANG HL, et al. Depression, anxiety, and nonalcoholic steatohepatitis[J]. Psychosom Med, 2006, 68 (4) :563-569.
|
[7] TAO YT, PAN Q, CHEN GY, et al. Personality and emotional states in patients with nonalcoholic fatty liver diseases[J]. J Prac Hepatol, 2017, 20 (6) :713-719. (in Chinese) 陶叶婷, 潘勤, 陈光榆, 等.非酒精性脂肪性肝病患者性格及情绪状态调查[J].实用肝脏病杂志, 2017, 20 (6) :713-719.
|
[8] YOUSSEF NA, ABDELMALEK MF, BINKS M, et al. Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease[J]. Liver Int, 2013, 33 (7) :1062-1070.
|
[9] TOMENO W, KAWASHIMA K, YONEDA M, et al. Non-alcoholic fatty liver disease comorbid with major depressive disorder:The pathological features and poor therapeutic efficacy[J]. J Gastroenterol Hepatol, 2015, 30 (6) :1009-1014.
|
[10] LIU YZ, WANG YX, JIANG CL. Inflammation:The common pathway of stress-related diseases[J]. Front Hum Neurosci, 2017, 11:316.
|
[11] MHLIG Y, ANTEL J, FCKER M, et al. Are bidirectional associations of obesity and depression already apparent in childhood and adolescence as based on high-quality studies? A systematic review[J]. Obes Rev, 2016, 17 (3) :235-249.
|
[12] STEWART KE, HALLER DL, SARGEANT C, et al. Readiness for behaviour change in non-alcoholic fatty liver disease:Implications for multidisciplinary care models[J]. Liver Int, 2015, 35 (3) :936-943.
|
[13] CELIKBILEK A, CELIKBILEK M, BOZKURT G. Cognitive assessment of patients with nonalcoholic fatty liver disease[J].Eur J Gastroenterol Hepatol, 2018, 30 (8) :944-950.
|
[14] FILIPOVIC'B, MARKOVIC'O, URIC'V, et al. Cognitive changes and brain volume reduction in patients with nonalcoholic fatty liver disease[J]. Can J Gastroenterol Hepatol, 2018, 2018:9638797.
|
[15] TONG M, NEUSNER A, LONGATO L, et al. Nitrosamine exposure causes insulin resistance diseases:Relevance to type2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease[J]. J Alzheimers Dis, 2009, 17 (4) :827-844.
|
[16] WEINSTEIN AA, de AVILA L, PAIK J, et al. Cognitive performance in individuals with non-alcoholic fatty liver disease and/or type 2 diabetes mellitus[J]. Psychosomatics, 2018, 59 (6) :567-574.
|
[17] FELIPO V, URIOS A, MONTESINOS E, et al. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy[J]. Metab Brain Dis, 2012, 27 (1) :51-58.
|
[18] SAYINER M, STEPANOVA M, PHAM H, et al. Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease[J]. BMJ Open Gastroenterol, 2016, 3 (1) :e000106.
|
[19] DAVID K, KOWDLEY KV, UNALP A, et al. Quality of life in adults with nonalcoholic fatty liver disease:Baseline data from the nonalcoholic steatohepatitis clinical research network[J].Hepatology, 2009, 49 (6) :1904-1912.
|
[20] GOLABI P, OTGONSUREN M, CABLE R, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with impairment of health related quality of life (HRQOL) [J]. Health Qual Life Outcomes, 2016, 14:18.
|
[21] TAO YT, YAN SY, CHEN GY, et al. Research on life quality in patients with nonalcoholic fatty liver diseases[J]. Chin Hepatol, 2016, 21 (12) :1017-1022. (in Chinese) 陶叶婷, 颜士岩, 陈光榆, 等.非酒精性脂肪性肝病患者生活质量调查[J].肝脏, 2016, 21 (12) :1017-1022.
|
[22] GOLABI P, SAYINER M, BUSH H, et al. Patient-reported outcomes and fatigue in patients with chronic hepatitis C infection[J]. Clin Liver Dis, 2017, 21 (3) :565-578.
|
[23] HUBER Y, BOYLE M, HALLSWORTH K, et al. Health-related quality of life in non-alcoholic fatty liver disease associates with hepatic inflammation[J]. Clin Gastroenterol Hepatol, 2018.[Epub ahead of print]
|
[24] TAPPER EB, LAI M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease:A prospective cohort study[J]. Hepatology, 2016, 63 (4) :1184-1189.
|
[25] JIANG QJ, HUANG L, LU KS, et al. Psychological stress:Classification of coping and physical and mental health[J].Chin Mental Health J, 1993, 7 (4) :145-147. (in Chinese) 姜乾金, 黄丽, 卢抗生, 等.心理应激:应对的分类与心身健康[J].中国心理卫生杂志, 1993, 7 (4) :145-147.
|
[26] WEN YF. Relationship between social mental factors and nonalcoholic fatty liver disease:A case-control study[J]. China J Health Psychol, 2018, 26 (4) :565-568. (in Chinese) 温贻芳.社会心理因素与非酒精性脂肪肝的关系[J].中国健康心理志, 2018, 26 (4) :565-568.
|
[27] CHEN CL, CHEN WN, PENG BW, et al. Differential study on the medical coping modes in the patients with young chronic hepatitis B and young fatty liver[J]. J Nurs Sci, 2008, 23 (7) :69-71. (in Chinese) 陈纯柳, 陈文娜, 彭碧文, 等.青年慢乙肝与脂肪肝患者医学应对方式差异比较[J].护理学杂志, 2008, 23 (7) :69-71.
|
[28] FANG Y, DAI LM, XIE F, et al. The effect of follow-up intervention on the self-efifcacy and coping styles among diabetic patients with non-alcoholic fatty liver[J]. Chin Nurs Manage, 2013, 13 (10) :106-109. (in Chinese) 方英, 戴莉敏, 谢菲, 等.随访干预对糖尿病合并非酒精性脂肪肝患者自我效能和应对方式的影响研究[J].中国护理管理, 2013, 13 (10) :106-109.
|
[29] MAZZONE L, POSTORINO V, DE PEPPO L, et al. Paediatric non-alcoholic fatty liver disease:Impact on patients and mothers’quality of life[J]. Hepat Mon, 2013, 13 (3) :e7871.
|
[30] KERKAR N, D’URSO C, van NOSTRAND K, et al. Psychosocial outcomes for children with nonalcoholic fatty liver disease over time and compared with obese controls[J]. J Pediatr Gastroenterol Nutr, 2013, 56 (1) :77-82.
|
[31] KARAIVAZOGLOU K, KALOGEROPOULOU M, ASSIMAKOPOULOS S, et al. Psychosocial issues in pediatric nonalcoholic fatty liver disease[J]. Psychosomatics, 2019, 60 (1) :10-17.
|
[32] KISTLER KD, MOLLESTON J, UNALP A, et al. Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2010, 31 (3) :396-406.
|